Stockscreener 앱 받기
10.32
2.89%
0.29
시간 외 거래:
10.50
0.18
+1.74%
Artiva Biotherapeutics Inc 주식(ARTV)의 최신 뉴스
Artiva Biotherapeutics Inc (ARTV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Artiva Biotherapeutics Inc (ARTV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
Insider Stock Purchases: July 24, 2026 - Quiver Quantitative
Thursday’s insider buys and sells: Artiva, StoneX and CoreWeave By Investing.com - Investing.com South Africa
Ra capital management, director, buys $58,306 of Artiva stock - Investing.com UK
Artiva Biotherapeutics Inc (ARTV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RA Capital Management acquires USD 2.62 million of Artiva Biotherapeutics common shares - Bitget
Form 4 Artiva Biotherapeutics Inc For: 23 July By Investing.com - Investing.com Nigeria
Form 13D/A ARTIVA BIOTHERAPEUTICS For: 23 July By Investing.com - Investing.com Nigeria
Ra capital management, director, buys $58,306 of Artiva stock By Investing.com - Investing.com Canada
Ra Capital Management buys $2.58m in Artiva Biotherapeutics stock By Investing.com - Investing.com Canada
Ra Capital Management buys $2.58m in Artiva Biotherapeutics stock - Investing.com
ARTV Options Volatility — NASDAQ:ARTV - TradingView
ARTV Options Chain — NASDAQ:ARTV - TradingView
Artiva Biotherapeutics Sets Deadline for 2026 Meeting - TipRanks
Artiva sets 2026 annual meeting for Sept. 8; stockholder notice deadline Aug. 1 - TradingView
Artiva Biotherapeutics (Nasdaq: ARTV) details 2026 meeting deadlines - Stock Titan
Major Insider Move Signals Growing Confidence in Artiva Biotherapeutics - TipRanks
New Form 4 - Moomoo
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Form 4 Artiva Biotherapeutics Inc For: 14 July By Investing.com - Investing.com Nigeria
Ra Capital Management funds buy $194k in Artiva Biotherapeutics stock By Investing.com - Investing.com South Africa
Ra Capital Management funds buy $194k in Artiva Biotherapeutics stock - Investing.com
ARTV Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue Development StageProfit Announcement - DonanımHaber
Is Artiva Biotherapeutics, Inc. (ARTV) outperforming other medical stocks this year? - MSN
Is Artiva Biotherapeutics, Inc. (ARTV) Outperforming Other Medical Stocks This Year? - Yahoo Finance
What date does Artiva Biotherapeutics, Inc.'s (ARTV) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
ARTV Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesProduct Revenue Analysis - dars.gov.et
Artiva Biotherapeutics Q1 2026 Earnings: Wider-than-Expected Loss Highlights Pipeline Burn RatePost-Earnings Drift - dars.gov.et
Artiva Biotherapeutics (ARTV) Slips Near Key Support Level; Traders Eye $9.13 FloorImbalance Zone - dars.gov.et
Artiva Biotherapeutics at H.C. Wainwright: allogeneic cell therapy push By Investing.com - Investing.com Canada
Artiva Biotherapeutics (ARTV) Gains Ground With Support Holding at $9.21SuperTrend Flip - dars.gov.et
Major Stake Boost Signals Growing Confidence in Artiva Biotherapeutics - TipRanks
Ra capital funds buy $292k Artiva Biotherapeutics stock in late June - Investing.com South Africa
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2000 Index - marketscreener.com
Form 4 Artiva Biotherapeutics Inc For: 29 June By Investing.com - Investing.com South Africa
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2500 Growth Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2000 Value Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM:ARTV) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 2000 Growth Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 3000E Growth Benchmark - marketscreener.com
Artiva Biotherapeutics, Inc.(NasdaqGM:ARTV) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Price to sales forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Price to book forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Enterprise value to revenue forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) added to Russell 3000 Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Price to earnings forward of Artiva Biotherapeutics, Inc. – NASDAQ:ARTV - TradingView
Artiva Biotherapeutics, Inc. advances AlloNK therapy toward Phase 3 in autoimmune disease - Traders Union
Artiva Biotherapeutics Inc (ARTV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Artiva Biotherapeutics, Inc. Actuals & Estimates (NASDAQ:ARTV) - TradingView
ARTV Forecast — Price Target — Prediction for 2027 - TradingView
ARTV Q1 2026 Earnings: EPS Surprise Misses Estimates, No Revenue ReportedGuidance Downgrade Alert - dars.gov.et
1.97%
0.83%
자본화:
|
볼륨(24시간):